N-of-1 Trials: Evidence-Based Clinical Care or Medical Research that Requires IRB Approval? A Practical Flowchart Based on an Ethical Framework
Bas C. Stunnenberg(Radboud University Nijmegen), Frans van Agt(Dutch Expert Centre for Screening), Tom Nijenhuis(Radboud University Nijmegen), Jaap Deinum(Radboud University Nijmegen), F.T.M. Huysmans(Dutch Expert Centre for Screening), Baziel G.M. van Engelen(Radboud University Nijmegen), Gert Jan van der Wilt(Radboud University Nijmegen)
Cited by 29
Related Papers
Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort
|The Lancet Diabetes & Endocrinology|2017|951
Enhanced passive Ca2+ reabsorption and reduced Mg2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia
|Journal of Clinical Investigation|2005|489
Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism
|JCI Insight|2017|275
Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial
|The Lancet Diabetes & Endocrinology|2016|268
Angiotensin II Contributes to Podocyte Injury by Increasing TRPC6 Expression via an NFAT-Mediated Positive Feedback Signaling Pathway
|American Journal Of Pathology|2011|209